163 related articles for article (PubMed ID: 35507766)
41. Donor substrate specificities of Gal beta 1,4GlcNAc alpha 2,6-sialyltransferase and Gal beta 1,3GalNAc alpha 2,3-sialyltransferase: comparison of N-acetyl and N-glycolylneuraminic acids.
Hamamoto T; Kurosawa N; Lee YC; Tsuji S
Biochim Biophys Acta; 1995 May; 1244(1):223-8. PubMed ID: 7766662
[TBL] [Abstract][Full Text] [Related]
42. Presence of cytidine 5'-monophospho-N-acetylneuraminic acid:Gal beta 1-3GalNAc-R alpha(2-3)-sialyltransferase in normal human leukocytes and increased activity of this enzyme in granulocytes from chronic myelogenous leukemia patients.
Baker MA; Kanani A; Brockhausen I; Schachter H; Hindenburg A; Taub RN
Cancer Res; 1987 Jun; 47(11):2763-6. PubMed ID: 3471317
[TBL] [Abstract][Full Text] [Related]
43. Branch specificity of bovine colostrum CMP-sialic acid: Gal beta 1----4GlcNAc-R alpha 2----6-sialyltransferase. Sialylation of bi-, tri-, and tetraantennary oligosaccharides and glycopeptides of the N-acetyllactosamine type.
Joziasse DH; Schiphorst WE; Van den Eijnden DH; Van Kuik JA; Van Halbeek H; Vliegenthart JF
J Biol Chem; 1987 Feb; 262(5):2025-33. PubMed ID: 3546284
[TBL] [Abstract][Full Text] [Related]
44. OP9 bone marrow stroma cells differentiate into megakaryocytes and platelets.
Matsubara Y; Ono Y; Suzuki H; Arai F; Suda T; Murata M; Ikeda Y
PLoS One; 2013; 8(3):e58123. PubMed ID: 23469264
[TBL] [Abstract][Full Text] [Related]
45. ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL.
Pietrobono S; Anichini G; Sala C; Manetti F; Almada LL; Pepe S; Carr RM; Paradise BD; Sarkaria JN; Davila JI; Tofani L; Battisti I; Arrigoni G; Ying L; Zhang C; Li H; Meves A; Fernandez-Zapico ME; Stecca B
Nat Commun; 2020 Nov; 11(1):5865. PubMed ID: 33203881
[TBL] [Abstract][Full Text] [Related]
46. Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis.
Petrosyan A; Holzapfel MS; Muirhead DE; Cheng PW
Mol Cancer Res; 2014 Dec; 12(12):1704-16. PubMed ID: 25086069
[TBL] [Abstract][Full Text] [Related]
47. Development of BODIPY labelled sialic acids as sialyltransferase substrates for direct detection of terminal galactose on N- and O-linked glycans.
Abukar T; Rahmani S; Thompson NK; Antonescu CN; Wakarchuk WW
Carbohydr Res; 2021 Feb; 500():108249. PubMed ID: 33545445
[TBL] [Abstract][Full Text] [Related]
48. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
[TBL] [Abstract][Full Text] [Related]
49. Packaging functionally important plasma proteins into the α-granules of human-induced pluripotent stem cell-derived megakaryocytes.
Zhang N; Newman PJ
J Tissue Eng Regen Med; 2019 Feb; 13(2):244-252. PubMed ID: 30556311
[TBL] [Abstract][Full Text] [Related]
50. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas.
Schneider F; Kemmner W; Haensch W; Franke G; Gretschel S; Karsten U; Schlag PM
Cancer Res; 2001 Jun; 61(11):4605-11. PubMed ID: 11389097
[TBL] [Abstract][Full Text] [Related]
52. Soluble interleukin-6 (IL-6) receptor with IL-6 stimulates megakaryopoiesis from human CD34(+) cells through glycoprotein (gp)130 signaling.
Sui X; Tsuji K; Ebihara Y; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
Blood; 1999 Apr; 93(8):2525-32. PubMed ID: 10194431
[TBL] [Abstract][Full Text] [Related]
53. Surface alpha 2-3- and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis.
Videira PA; Amado IF; Crespo HJ; Algueró MC; Dall'Olio F; Cabral MG; Trindade H
Glycoconj J; 2008 Apr; 25(3):259-68. PubMed ID: 18080182
[TBL] [Abstract][Full Text] [Related]
54. Regulation of alpha 2,3-sialyltransferase expression correlates with conversion of peanut agglutinin (PNA)+ to PNA- phenotype in developing thymocytes.
Gillespie W; Paulson JC; Kelm S; Pang M; Baum LG
J Biol Chem; 1993 Feb; 268(6):3801-4. PubMed ID: 8440675
[TBL] [Abstract][Full Text] [Related]
55. The Hexapeptide inhibitor of Galbeta 1,3GalNAc-specific alpha 2,3-sialyltransferase as a generic inhibitor of sialyltransferases.
Lee KY; Kim HG; Hwang MR; Chae JI; Yang JM; Lee YC; Choo YK; Lee YI; Lee SS; Do SI
J Biol Chem; 2002 Dec; 277(51):49341-51. PubMed ID: 12379642
[TBL] [Abstract][Full Text] [Related]
56. Mouse beta-galactoside alpha 2,3-sialyltransferases: comparison of in vitro substrate specificities and tissue specific expression.
Kono M; Ohyama Y; Lee YC; Hamamoto T; Kojima N; Tsuji S
Glycobiology; 1997 Jun; 7(4):469-79. PubMed ID: 9184827
[TBL] [Abstract][Full Text] [Related]
57. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
[TBL] [Abstract][Full Text] [Related]
58. Differentiation-dependent expression of alpha-2,3-sialyltransferase in rabbit corneal epithelium.
Matic M; Petrov I; Stegman Z; Buku A; Wolosin JM
Invest Ophthalmol Vis Sci; 1998 May; 39(6):905-12. PubMed ID: 9579470
[TBL] [Abstract][Full Text] [Related]
59. Characterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.
Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
J Proteome Res; 2012 Apr; 11(4):2609-18. PubMed ID: 22329400
[TBL] [Abstract][Full Text] [Related]
60. Kinetic properties and acceptor substrate preferences of two kinds of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain.
Kojima N; Lee YC; Hamamoto T; Kurosawa N; Tsuji S
Biochemistry; 1994 May; 33(19):5772-6. PubMed ID: 8180204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
